Dr Reddy's receives DCGI approval for esophageal cancer drug Zytorvi
The drug has been approved in combination with cisplatin and paclitaxel for the first-line treatment of adult patients with unresectable advanced, recurrent, or metastatic ESCC
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.